Perceptive Advisors LLC Nanobiotix S.A. Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
A detailed history of Perceptive Advisors LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Perceptive Advisors LLC holds 266,093 shares of NBTX stock, worth $1.11 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
266,093
Previous 555,066
52.06%
Holding current value
$1.11 Million
Previous $3.19 Million
76.09%
% of portfolio
0.03%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding NBTX
# of Institutions
17Shares Held
6.5MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$23.4 Million5.5% of portfolio
-
Black Rock Inc. New York, NY239KShares$994,2730.0% of portfolio
-
Old Mission Capital LLC48.5KShares$201,6510.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$96,8570.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny13.5KShares$55,9600.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $145M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...